Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy
- PMID: 38373305
- DOI: 10.7326/L24-0045
Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy
Erratum for
-
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.Ann Intern Med. 2023 Dec;176(12):1577-1585. doi: 10.7326/M23-1756. Epub 2023 Nov 14. Ann Intern Med. 2023. PMID: 37956428 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous